AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
+36.68%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$906M
AUM Growth
+$906M
Cap. Flow
+$142M
Cap. Flow %
15.66%
Top 10 Hldgs %
96.53%
Holding
17
New
1
Increased
–
Reduced
4
Closed
–

Top Buys

1
THRD
Third Harmonic Bio
THRD
$207M

Top Sells

1
AKRO icon
Akero Therapeutics
AKRO
$42.2M
2
DAWN icon
Day One Biopharmaceuticals
DAWN
$16M
3
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$5.15M
4
REPL icon
Replimune Group
REPL
$1.75M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
THRD
1
DELISTED
Third Harmonic Bio
THRD
$207M 22.84%
+10,907,859
New +$207M
DAWN icon
2
Day One Biopharmaceuticals
DAWN
$769M
$164M 18.06%
8,169,171
-799,134
-9% -$16M
KYMR icon
3
Kymera Therapeutics
KYMR
$2.95B
$150M 16.52%
6,875,698
– –
DYN icon
4
Dyne Therapeutics
DYN
$1.92B
$113M 12.52%
8,934,902
– –
REPL icon
5
Replimune Group
REPL
$422M
$53.7M 5.92%
3,108,300
-101,327
-3% -$1.75M
VIGL
6
DELISTED
Vigil Neuroscience
VIGL
$53.1M 5.86%
5,836,874
– –
GBIO icon
7
Generation Bio
GBIO
$40.4M
$44M 4.85%
8,278,876
– –
JBIO
8
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$38.6M 4.26%
2,327,909
-310,388
-12% -$5.15M
AKRO icon
9
Akero Therapeutics
AKRO
$3.74B
$33.9M 3.74%
994,251
-1,238,000
-55% -$42.2M
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
$17.8M 1.97%
5,018,178
– –
IRON icon
11
Disc Medicine
IRON
$2.07B
$8.62M 0.95%
5,254,365
– –
XLO icon
12
Xilio Therapeutics
XLO
$36.3M
$8.03M 0.89%
2,759,344
– –
DNTH icon
13
Dianthus Therapeutics
DNTH
$759M
$4.9M 0.54%
3,476,536
– –
FSTX
14
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.07M 0.34%
599,524
– –
TECX
15
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$2.91M 0.32%
4,520,863
– –
SPRO icon
16
Spero Therapeutics
SPRO
$116M
$2.06M 0.23%
1,031,160
– –
VRDN icon
17
Viridian Therapeutics
VRDN
$1.5B
$1.85M 0.2%
90,072
– –